News

CereMetrix Corp. Introduces Enhancements to its Advanced Medical Imaging and Analytics Platform
May 04, 2021
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications.
Micro Medical Solutions Receives FDA Breakthrough Device Designation for MicroStent Vascular Stent
May 04, 2021
Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. Micro Medical Solutions (MMS), focused on the treatment of CLTI, today announced that the U.S. Food and Drug Administration (FDA)…
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™
April 21, 2021
Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the…
Five-year Patient-level Meta-analysis of ILLUMENATE EU RCT and Pivotal Study Results Confirms Safety Profile of Philips Stellarex .035” Low-dose Drug-Coated Balloon
April 20, 2021
Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal angioplasty (PTA), the current standard of care.
Study Shows the Use of Temporary Intravascular Shunts Improves Early Limb Salvage after Extremity Vascular Injury
April 14, 2021
Rosemont, Illinois, April 14, 2021 – A multicente
The Society for Vascular Surgery Partners with the Academy for Surgical Coaching to Take Wellness Support to the Next Level
April 08, 2021
New customized, peer-to-peer coaching program fills gap in health and wellness intervention for vascular surgeons. The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching today announced a partnership to develop a first-of-its-…
Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial
April 05, 2021
Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application…
Next-Generation Microcatheter Platform Earns CE Mark Approval
March 17, 2021
Transit Scientific announced it received CE Mark approval in the European Union for its non-tapered metal alloy XO Cross® Microcatheter platform.
Cook Medical receives FDA Breakthrough Device Designation for Zenith® Fenestrated+ Endovascular Graft
March 02, 2021
Cook Medical’s Zenith® Fenestrated+ Endovascular Graft (ZFEN+) product has received Breakthrough Device designation from the US Food and Drug Administration (FDA). This designation is granted for devices that have the potential to provide more…
PatenSee Initiates First In-Human Trial with its Contactless Imaging Surveillance System for Patients Undergoing Hemodialysis
February 16, 2021
Trial to provide first clinical experience in fistula surveillance for early detection and prediction of fistula stenosis
Endovascular Aneurysm Repair Linked to Higher Readmission Rates Compared to Open Repair
February 10, 2021
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and current…
Back to Top